Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CD172a Rat anti-Mouse, BUV563, Clone: P84, BD Biosciences™

Catalog No. BDB741349 Shop All BD Biosciences Products
Change view
Click to view available options
Quantity:
50 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
BDB741349 50 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. BDB741349 Supplier BD Biosciences Supplier No. 741349
Only null left
Add to Cart
Add to Cart

Rat Monoclonal Antibody

CD172a Monoclonal antibody specifically detects CD172a in Mouse samples. It is validated for Flow Cytometry
TRUSTED_SUSTAINABILITY

Specifications

Antigen CD172a
Applications Flow Cytometry
Classification Monoclonal
Clone P84
Conjugate Brilliant Ultraviolet 563
Formulation Aqueous buffered solution containing ≤0.09% sodium azide.
Gene Alias Sirpa; Sirp alpha; Sirpα; Bit; SHPS-1; p84; Ptpns1
Host Species Rat
Immunogen Membrane fractions from mouse brain
Quantity 50 μg
Regulatory Status RUO
Primary or Secondary Primary
Target Species Mouse
Content And Storage Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with BD Horizon BUV563 under optimal conditions that minimize unconjugated dye and antibody.
Isotype IgG1 κ
Show More Show Less
WARNING: Reproductive Harm - www.P65Warnings.ca.gov
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.